Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

June 2014 - FRMC

06/18/2014
Results from the DESCARTES (Durable Effect of PCSK9 Antibody Compared with Placebo Study) trial found that the investigational PCSK9 inhibitor, evolocumab, for the treatment of hyperlipidemia significantly reduced low-density lipoprotein...
Results from the DESCARTES (Durable Effect of PCSK9 Antibody Compared with Placebo Study) trial found that the investigational PCSK9 inhibitor, evolocumab, for the treatment of hyperlipidemia significantly reduced low-density lipoprotein...
Results from the DESCARTES...
06/18/2014
First Report Managed Care
06/18/2014
Diabetes medications are insulin-dependent, and the efficacy of these drugs diminishes when the function of pancreatic islet ß-cells declines during the progression of diabetes. Some diabetes drugs can cause weight gain in patients, which...
Diabetes medications are insulin-dependent, and the efficacy of these drugs diminishes when the function of pancreatic islet ß-cells declines during the progression of diabetes. Some diabetes drugs can cause weight gain in patients, which...
Diabetes medications are...
06/18/2014
First Report Managed Care
06/18/2014
Inadequate health literacy is a pervasive problem with major implications for reduced health status and health disparities. Education is a fundamental strategy of stroke prevention and treatment, but the effect of health literacy on stroke...
Inadequate health literacy is a pervasive problem with major implications for reduced health status and health disparities. Education is a fundamental strategy of stroke prevention and treatment, but the effect of health literacy on stroke...
Inadequate health literacy is a...
06/18/2014
First Report Managed Care
06/18/2014
The IMS Health Institute for Healthcare Informatics issued a report saying the US healthcare system could save in annual healthcare costs if medications were used responsibly.
The IMS Health Institute for Healthcare Informatics issued a report saying the US healthcare system could save in annual healthcare costs if medications were used responsibly.
The IMS Health Institute for...
06/18/2014
First Report Managed Care

Department

Managed Care Q&A
06/18/2014
First Report Managed Care conducted an interview with Norm Smith, one of our Editorial Advisory Board members, to discuss how the Patient Protection and Affordable Care Act (ACA) is impacting the managed markets, including costs, coverage,...
First Report Managed Care conducted an interview with Norm Smith, one of our Editorial Advisory Board members, to discuss how the Patient Protection and Affordable Care Act (ACA) is impacting the managed markets, including costs, coverage,...
First Report Managed Care...
06/18/2014
First Report Managed Care
Conference Insider
06/18/2014
Orlando—By now, more than 4 years since the passage of the Patient Protection and Affordable Care Act (ACA), patients, providers, payers, and pharmaceutical companies have become accustomed to an evolving healthcare industry. Michael Lovdal,...
Orlando—By now, more than 4 years since the passage of the Patient Protection and Affordable Care Act (ACA), patients, providers, payers, and pharmaceutical companies have become accustomed to an evolving healthcare industry. Michael Lovdal,...
Orlando—By now, more than 4...
06/18/2014
First Report Managed Care

Advertisement

Advertisement

Advertisement